6.84

11.04% 0.68

After Hours: 6.94 0.10 +1.46%

Nu Skin Enterprises Inc (NUS)

Overview News Price History Option Chain Discussions Forecast Dividend History

Nu Skin Enterprises Inc stock is traded at $6.84, with a volume of 1.17M. It is up +11.04% in the last 24 hours and up +7.55% over the past month. Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.

Previous Close:

$6.16

Open:

$6.595

24h Volume:

1.17M

Relative Volume:

1.63

Market Cap:

$305.84M

Revenue:

$1.97B

Net Income/Loss:

$8.60M

P/E Ratio:

38.00

EPS:

0.18

Net Cash Flow:

$60.15M

1W Performance:

+10.50%

1M Performance:

+7.55%

6M Performance:

+4.43%

1Y Performance:

-46.48%

1-Day Range:

$6.59

$7.35

1-Week Range:

$5.63

$7.35

52-Week Range:

$5.32

$14.00

Nu Skin Enterprises Inc Stock (NUS) Company Profile

Name

Nu Skin Enterprises Inc

Sector

Consumer Defensive (245)

Industry

Household & Personal Products (33)

Phone

801-345-1000

Address

75 WEST CENTER ST, PROVO, UT

Employee

11,300

Twitter

@NuSkinEnt

Next Earnings Date

2024-11-07

Latest SEC Filings

NUS's Discussions on Twitter

Compare NUS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NUS Nu Skin Enterprises Inc	6.84	305.84M	1.97B	8.60M	60.15M	0.18
PG Procter Gamble Co	157.66	376.35B	83.93B	15.50B	15.03B	6.30
UL Unilever Plc Adr	62.50	155.93B	65.10B	6.16B	0	2.4569
CL Colgate Palmolive Co	89.81	73.33B	19.95B	2.90B	3.47B	3.54
KVUE Kenvue Inc	24.44	46.01B	15.46B	1.03B	1.34B	0.53
KMB Kimberly Clark Corp	133.05	43.25B	19.75B	2.47B	2.39B	7.34

Nu Skin Enterprises Inc Stock (NUS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-31-23	Downgrade	Jefferies	Buy → Hold
Feb-12-21	Downgrade	DA Davidson	Buy → Neutral
Oct-02-20	Upgrade	BofA Securities	Underperform → Neutral
Jul-02-20	Upgrade	DA Davidson	Neutral → Buy
Jul-02-20	Upgrade	Jefferies	Hold → Buy
Mar-09-20	Downgrade	Deutsche Bank	Buy → Hold
Dec-05-19	Resumed	Citigroup	Neutral
Nov-06-19	Downgrade	Citigroup	Buy → Neutral
Oct-30-19	Upgrade	Stifel	Sell → Hold
Jul-17-19	Downgrade	DA Davidson	Buy → Neutral
Jul-17-19	Downgrade	Jefferies	Buy → Hold
Jun-19-19	Reiterated	BofA/Merrill	Underperform
May-01-19	Reiterated	BofA/Merrill	Underperform
May-01-19	Upgrade	Deutsche Bank	Hold → Buy
Apr-12-19	Reiterated	BofA/Merrill	Underperform
Mar-25-19	Downgrade	Stifel	Hold → Sell
Dec-06-18	Reiterated	BofA/Merrill	Underperform
Oct-10-18	Initiated	DA Davidson	Buy
Aug-03-18	Upgrade	Stifel	Sell → Hold
Jun-14-18	Initiated	Jefferies	Buy
Feb-16-18	Reiterated	Stifel	Sell
Jan-23-18	Reiterated	Citigroup	Buy

View All

Nu Skin Enterprises Inc Stock (NUS) Latest News

10:53 AM

Nu Skin Enterprises, Inc. (NYSE:NUS) Stake Lowered by Deerfield Management Company L.P. Series C - MarketBeat

10:53 AM

01:55 AM

Nu Skin Enterprises, Inc. (NYSE:NUS) Q1 2025 Earnings Call Transcript - Insider Monkey

01:55 AM

May 09, 2025

Nu skin outlines Prysm iO launch and targets $355M-$390M Q2 2025 revenue - MSN

May 09, 2025

Susquehanna International Group LLP Has $4.84 Million Holdings in Nu Skin Enterprises, Inc. (NYSE:NUS) - MarketBeat

May 09, 2025

Nu Skin Q1 2025 slides: Revenue declines 12.7%, outlook remains cautious By Investing.com - Investing.com South Africa

May 09, 2025

Nu Skin Q1 2025 slides: Revenue declines 12.7%, outlook remains cautious - Investing.com Australia

May 09, 2025

CastleKnight Management LP Has $544,000 Position in Nu Skin Enterprises, Inc. (NYSE:NUS) - MarketBeat

May 09, 2025

Nu Skin Enterprises Q1 2025 Earnings Call Transcript - MarketBeat

May 09, 2025